RxDoctor Payments Data

Jose Velez Velez, MD

Neurology · Sabana Grande, PRNPI 1295181188

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 19.8% — the pattern of someone who eats at a lot of different presentations.

$4,836in general payments, 2019–2025

Across 126 payments — averaging $38.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$957
  • EMD Serono, Inc.$913
  • E.r. Squibb & Sons, L.L.C.$635
  • Novartis$614
  • AbbVie$391
  • Genentech USA, Inc.$250
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$4,836100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,836 in reported general payments places this provider in the 75th percentile of 129 neurology providers in Puerto Rico.

See all neurology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$27,252
Medicare patients
70
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Galantamine Hbr271$29,063
Carbidopa-LevodopaCarbidopa/Levodopa229$9,663
Memantine Hcl245$8,522
Donepezil Hcl409$4,327
Citalopram HbrCitalopram Hydrobromide516$3,964
Primidone83$2,757
Propranolol Hcl102$1,919
Levetiracetam40$1,540
Topiramate85$897
Gabapentin135$841
Carbamazepine26$819
Escitalopram Oxalate69$778
Trazodone Hcl88$768
ClopidogrelClopidogrel Bisulfate55$767
Sumatriptan Succinate66$708

Paid to pharmacies, not to this prescriber.

Other neurology in Sabana Grande

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →